Danielle Craig

Danielle Craig serves as the Regulatory Affairs Lead for the Americas at CEPI since June 2021, overseeing regulatory aspects of clinical trials and product approvals. Prior to this role, Danielle held various leadership positions in regulatory affairs at DynPort Vaccine Company LLC, including Sr. Director of Regulatory Affairs & Quality Systems, where responsibilities encompassed managing IND submissions and regulatory guidance for product development. Previous experience includes roles at Prometic, Emergent BioSolutions, and positions in document control and inventory management at Schuler Books and Music, and Michigan State University. Danielle holds a B.S. in Genomics and Molecular Genetics from Michigan State University and has completed graduate studies in Bioscience Regulatory Affairs at Johns Hopkins University.